Gene Query: MZT2A

Dataset Description Geneva Score
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 40.92
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 30.22
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 29.67
SLAM-seq for K562 endogenous mRNA decay 28.45
Triple vectors expand AAV transfer capacity in the retina 26.75
Active translatome profiling with RiboLace in MCF7 cells 26.41
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 25.27
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 22.95
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 21.53
Regulation of highly expressed hCINAP on translatome 21.16
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 18.87
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 18.81
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 18.59
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 18.55
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 17.88
The comparison of high-throughput single-cell RNA-seq methods 17.63
Seletive inhibition of CDK9 in DLBCL cell lines 17.1
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 16.98
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 16.44
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 16.27
Global analysis of enhancer targets: Mosaic-seq 16.07
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 15.91
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 15.11
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 15.07
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 14.84
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 14.62
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 14.49
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 14.48
Single-nucleotide-resolution mapping of HBV promoters using CAGE 14.43
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 14.21
Total RNA-seq in ALL-SIL upon JQ1 inhibition 13.96
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 13.58
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 13.43
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 13.38
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 13.25
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 13.14
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 13.12
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  12.91
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 12.58
HNF1A deficiency impairs β-cell fate, granule maturation and function 12.36
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 12.15
LNCaP treated with iBET 11.82
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 11.73
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 11.57
CROP-Seq in Primary Human T Cells 11.48
Gene expression profiling of leukemia cells following asparagine depletion 11.37
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 11.32
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 11.27
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 11.27
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 11.27
DART-seq: an antibody-free method for global m6A detection 11.16
Identification of transcription start sites for human A549 cell line using ReCappable-seq 11.14
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 11.03
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 11.02
RNA-seq of naive and primed ES cells (NHSM) 10.78
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 10.59
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 10.55
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 10.42
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 10.42
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 10.4
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.39
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.12
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.88
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 9.74
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 9.45
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 9.42
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.36
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 9.35
U1 snRNP telescripting regulates size-function stratified human genome 9.34
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.25
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.23
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 9.22
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 9.22
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 9.15
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 9.12
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 8.98
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 8.93
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 8.86
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 8.78
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 8.73
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 8.73
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 8.64
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.62
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.62
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.61
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.61
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 8.59
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 8.59
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 8.55
EP400 is required for Max and MCPyV mediated gene activation 8.47
RNA-seq in transgenic cells 8.44
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 8.29
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 8.28
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 8.23
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 8.2
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.07
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 7.95
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 7.93
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.87
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 7.84
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.81
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.71
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 7.71
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.69
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.66
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.63
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.63
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 7.62
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 7.62
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 7.61
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.6
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 7.58
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.52
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 7.52
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 7.5
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.5
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.5
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 7.47
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.47
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.42
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 7.37
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.36
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.32
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.3
Ro60-knockout cells 7.2
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 7.18
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 7.16
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 7.12
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.07
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 7.03
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 6.96
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 6.96
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.91
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 6.87
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 6.83
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 6.83
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 6.71
Human Treg IL-12 stimulation 6.7
Mutational landscape of splicing genes and functional consequences across 33 cancer types 6.62
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 6.59
Epigenomic landscape during organ formation in human early embryos 6.54
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 6.5
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 6.48
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 6.48
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 6.45
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 6.44
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 6.44
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.43
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 6.42
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 6.38
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 6.37
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 6.35
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.34
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 6.32
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 6.32
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.31
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.3
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.25
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 6.24
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.23
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 6.23
Functional role of CPPED1 in trophoblasts. 6.15
Paxillin regulates genomic networks in prostate cancer [C4-2] 6.15
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 6.14
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 6.13
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 6.13
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 6.12
PRDM1 inhibits proliferation of human colon cancer organoids 6.1
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.08
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.08
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 6.08
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 6.04
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 6.03
Impact of dieldrin on transcription in Jurkat T cells 6.02
Real-time observation of light-controlled transcription in living cells 6.01
Differential gene expression profiles in imatinib-resistant cell lines 6.01
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.0
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.0
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 5.99
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.98
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.98
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.92
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 5.89
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.88
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.88
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 5.85
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 5.84
RNAseq of cell lines with knocked in ESR1 mutations 5.81
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.79
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 5.78
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 5.78
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.75
Global Mapping of Human RNA-RNA Interactions 5.73
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.63
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 5.62
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.59
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.59
MCF-7 as a model for functional analysis of breast cancer risk variants 5.59
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.56
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.56
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.55
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.55
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 5.54
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.51
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.51
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.51
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.44
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.43
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.42
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 5.41
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.41
Direct Isolation and Characterization of Human Nephron Progenitors. 5.34
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 5.23
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.22
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 5.21
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.18
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 5.12
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 5.11
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.08
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 5.02
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.01
Aneuploidy triggers an immune response 4.99
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 4.98
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.92
RNA-Sequencing of HepG2 cells treated with TGFBeta 4.88
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.88
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 4.86
Biological effect of chronic mistranslation in mammalian cells 4.86
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.8
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.8
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 4.75
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.74
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 4.74
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 4.73
RNA-Seq of PRMT1 overexpression ECA109 cells 4.66
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 4.63
High-throughput sequencing of pluripotent cells 4.62
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.61
HEK293 Heat-shock experiment 4.6
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 4.59
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.55
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.53
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.51
scRNASeq analysis of cycling cardiomyocytes 4.46
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.37
RNA-seq analysis of control and Myc-induced U2OS cells 4.34
Systematic discovery of endogenous human ribonucleoprotein complexes 4.25
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.24
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.24
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.22
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 4.21
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 4.2
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.2
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 4.18
Single-cell analysis of human kidney organoids 4.16
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.11
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 4.1
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 4.08
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 4.07
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.0
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.0
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.0
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.0
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 3.97
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.97
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 3.93
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.89
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.89
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 3.88
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.87
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.86
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 3.81
Gene expression signatures of innate lymphoid cells from human blood 3.81
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 3.81
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 3.78
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 3.77
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.75
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 3.7
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.68
miRNAs affected by antagomiR-17 treatment 3.61
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 3.57
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 3.57
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.57
A20 regulates canonical wnt-signaling through an interaction with RIPK4 3.56
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 3.56
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 3.54
Ebola virus (EBOV) infection of ARPE-19 cells 3.53
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.52
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 3.48
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.48
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.46
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.46
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.45
Copper Regulation of HIF-1 Transcription Activity 3.45
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.41
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.41
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.38
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 3.37
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.35
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.35
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.35
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.33
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.31
ARID1A and ARID1B loss in HCT116 cells 3.27
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.27
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.27
The transcriptome effect of overexpressing EZH2 in MCF7 3.26
Transcriptome sequencing of K-562 cells 3.23
Comparative Analysis of Cas9 Activators Across Multiple Species 3.21
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.18
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.17
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.16
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.13
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.12
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.1
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.07
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.07
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.05
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.04
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.0
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.99
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.99
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.94
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.92
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.91
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.89
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.87
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.79
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.77
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.76
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.72
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 2.72
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.67
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.67
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.66
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.66
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.64
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.63
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.63
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 2.63
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.58
Global response to chemotherapy-induced apoptosis 2.56
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.52
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.44
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.41
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 2.4
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 2.4
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.4
Effect of FGF13 depletion on the H460 cell line 2.38
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.34
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.34
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.34
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.34
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.33
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.26
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.26
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.22
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 2.2
Human T-cell lymphoblastic lymphoma samples and control thymuses 2.2
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.16
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 2.15
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.11
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.11
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.11
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.08
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.06
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 2.06
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.03
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.01
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.0
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.0
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.0
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.98
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.98
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.98
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.9
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.9
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.88
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.88
Ribosome profiling upon inhibition of eIF4A 1.88
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.87
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.86
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.83
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.83
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.83
Transcriptional responses of melanoma cells to BRAF inhibition 1.83
Iron response of HepG2 cells 1.82
quanTIseq: quantifying immune contexture of human tumors 1.77
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.76
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.74
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.74
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.74
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.73
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.64
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 1.63
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 1.61
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.56
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.54
Expression profiling of MCF-7 cells with treatment of TCDD 1.54
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.52
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.49
Regulatory network controlling tumor-promoting inflammation in human cancers 1.49
Hepatic transcriptome of pediatric hepatoblastoma. 1.48
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.47
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 1.47
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.45
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.44
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.43
Expression analysis of the TAF1 syndrome 1.43
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.43
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.43
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.42
Functional significance of the HIV-1 Tat signature amino acid residues 1.39
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.36
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.35
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.35
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.33
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.31
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.31
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.3
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.3
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.3
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.29
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.27
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.24
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.24
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.2
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.2
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.19
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.19
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.16
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.15
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.13
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.1
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.08
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 1.07
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 1.07
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.07
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.02
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.01
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.99
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.98
Preclinical model of obesity and ER-positive breast cancer 0.98
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.95
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.89
FBXW7 modulates stress response by post-translational modification of HSF1 0.83
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.83
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.82
AUF-1 affected genes in human skin cells 0.82
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.79
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.79
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.77
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.71
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.71
Human Treg NaCl stimulation 0.69
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.67
Impact on erythroid progenitor type on erythroid differntiation 0.66
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.6
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.57
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.56
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.56
Effect of ILF3 on translation during homeostasis and the antiviral response 0.53
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.53
Transcriptome-wide modulation of splicing by the exon junction complex 0.51
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.51
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.49
The circadian transcriptional landscape in primary human mammary epithelial cells 0.47
SRSF1 role in cellular gene expression and splicing 0.44
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.41
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.4
RNA editing in nascent RNA affects pre-mRNA splicing 0.38
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.35
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.31
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.31
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.31
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.28
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.28
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.27
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.27
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.24
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.21
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.21
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.21
BACH2 in human plasma cell fate decision 0.2
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.19
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.12
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.11
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.08
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.08
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.05
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.04
The role of m6A/m-RNA methylation in stress response regulation 0.04
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.04
Nutritional control of protein translation 0.03
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 0.0
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation